MEMBER SPACE Login
"In accordance with the General European Regulation on the protection of individuals with regard to the processing of personal data and on the free movement of such data (RGPD) and the "Data Protection Act" of 6 January 1978 as amended, you have the right to access, rectify, oppose, delete (or "right to oblivion") or limit the processing of your personal data. You also have the right to withdraw your consent at any time by contacting XXXX . Finally, you have the possibility to lodge a complaint with a supervisory authority".
Dr. Elvire Pons-Tostivint (right) has been awarded the Alain Depierre 2021 prize of €20,000 by the IFCT (Intergroupe Francophone de Cancérologie Thoracique), for the project: “Study of…
Read more
On the occasion of the “Virades de l’espoir” which took place on September 26, the television team of France 5, for the mini series in vivo of…
Read more
FIRST GENERAL RESPIRATORY HEALTH ASSESSMENT For the first time, the Société de Pneumologie de Langue Française (SPLF), in partnership with seventeen patient, user and healthcare professional organizations,…
Read more
Mickaël Le Vern is a general engineer graduated from Arts et Métiers ParisTech and holds a Master degree in Civil Engineering from Laval University in Canada. After…
Read more
The first cardiopulmonary transplant in Nantes took place on April 12, 1988. Since then, the pioneers of the transplant have retired: our surgeons, Pr Jean-Luc Michaud and…
Read more
Discover the Third LUNG O2 Newsletter: On the program : Edito by Pr François-Xavier Blanc, Presentation of a cluster publication : Dilasser F et al. Essential role…
Read more
Air quality monitoring associations, including Air Pays de la Loire, calculate and publish every day an air quality index called the ATMO index. This indicator evolves in…
Read more
Discover the second LUNG O2 Newsletter : On the program : Edito by Pr François-Xavier Blanc, Presentation of a cluster publication : Blondy T et al, Involvement…
Read more
On Monday, October 5, 2020, the kick-off meeting for the development of the Mint application took place. This meeting was held at the Laennec hospital in the…
Read more
PDC*line Pharma recently announced that two new patient cohorts have been opened in the Phase I/II clinical trial PDC-LUNG-101 for its therapeutic vaccine candidate PDC*lung01 in non-small…
Read more